HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dooil Jeoung Selected Research

Insect Bites and Stings (Insect Bite)

10/2019FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dooil Jeoung Research Topics

Disease

43Neoplasms (Cancer)
05/2022 - 04/2006
22Inflammation (Inflammations)
01/2021 - 02/2008
19Testicular Neoplasms (Testicular Cancer)
01/2021 - 04/2006
10Leukemia
01/2021 - 02/2008
10Melanoma (Melanoma, Malignant)
01/2021 - 01/2008
6Atopic Dermatitis (Atopic Eczema)
01/2021 - 05/2008
6Hypersensitivity (Allergy)
01/2021 - 02/2008
6Anaphylaxis (Anaphylactic Shock)
01/2020 - 04/2011
6Neoplasm Metastasis (Metastasis)
02/2017 - 01/2011
3Stomach Neoplasms (Stomach Cancer)
01/2021 - 06/2006
3Carcinogenesis
09/2019 - 03/2008
3Lung Neoplasms (Lung Cancer)
09/2019 - 07/2007
2Breast Neoplasms (Breast Cancer)
10/2020 - 07/2007
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 01/2011
2Hypoxia (Hypoxemia)
01/2017 - 12/2014
2Atherosclerosis
03/2013 - 12/2008
2Asthma (Bronchial Asthma)
04/2011 - 06/2009
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
12/2019
1Insect Bites and Stings (Insect Bite)
10/2019
1Sarcoma (Soft Tissue Sarcoma)
09/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2018
1Alzheimer Disease (Alzheimer's Disease)
10/2018
1Huntington Disease (Huntington's Disease)
10/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018

Drug/Important Bio-Agent (IBA)

31AntigensIBA
01/2021 - 04/2006
15Pharmaceutical PreparationsIBA
01/2021 - 07/2009
12Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2006
11MicroRNAs (MicroRNA)IBA
05/2022 - 10/2014
8Peptides (Polypeptides)IBA
01/2018 - 04/2006
6Histones (Histone)IBA
01/2020 - 11/2008
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2019 - 12/2013
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 08/2006
5histone deacetylase 3IBA
12/2018 - 07/2012
5CytokinesIBA
01/2018 - 06/2009
5IntegrinsIBA
01/2017 - 01/2011
5celastrolIBA
08/2015 - 06/2009
5NF-kappa B (NF-kB)IBA
02/2010 - 01/2008
4Paclitaxel (Taxol)FDA LinkGeneric
11/2018 - 10/2014
4Anti-Allergic Agents (Antiallergic Agents)IBA
09/2017 - 02/2008
4Protein Glutamine gamma Glutamyltransferase 2IBA
10/2014 - 08/2006
4Phosphotransferases (Kinase)IBA
11/2009 - 02/2008
4Complementary DNA (cDNA)IBA
11/2008 - 04/2004
3Histone Deacetylases (Histone Deacetylase)IBA
01/2021 - 10/2014
3DinitrofluorobenzeneIBA
01/2020 - 05/2008
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2013
3Immunoglobulin E (IgE)IBA
10/2019 - 04/2011
3Hyaluronic Acid (Hyaluronan)IBA
08/2008 - 01/2008
2dinitrophenyl-human serum albumin conjugateIBA
01/2021 - 01/2020
2LigandsIBA
10/2020 - 01/2018
2Histone Deacetylase InhibitorsIBA
01/2020 - 10/2019
2Mitogen-Activated Protein KinasesIBA
01/2020 - 09/2019
2TOR Serine-Threonine KinasesIBA
01/2020 - 09/2019
2Irinotecan (Camptosar)FDA LinkGeneric
12/2019 - 02/2017
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2019 - 02/2017
2arginyl-leucyl-tyrosyl-glutamic acidIBA
12/2019 - 02/2017
2AllergensIBA
10/2019 - 06/2009
2ErbB Receptors (EGF Receptor)IBA
09/2019 - 04/2011
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2019 - 01/2007
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2019 - 01/2010
2Cisplatin (Platino)FDA LinkGeneric
11/2018 - 07/2007
2Conditioned Culture MediaIBA
01/2018 - 04/2014
2ChemokinesIBA
01/2018 - 05/2015
2Transcription Factors (Transcription Factor)IBA
01/2018 - 05/2014
2Hexosaminidases (Hexosaminidase)IBA
01/2018 - 10/2014
2Fibronectins (Fibronectin)IBA
01/2017 - 01/2011
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2017 - 01/2013
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2017 - 05/2014
2Heme Oxygenase-1IBA
01/2017 - 12/2014
2Small Interfering RNA (siRNA)IBA
01/2017 - 08/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 06/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 05/2014
2AntioxidantsIBA
03/2013 - 08/2012
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2012 - 01/2010
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2012 - 01/2010
2CystamineIBA
02/2010 - 01/2008
2Tetradecanoylphorbol AcetateIBA
02/2010 - 06/2009
2p38 Mitogen-Activated Protein KinasesIBA
01/2010 - 06/2006
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2009 - 07/2009
2AutoantibodiesIBA
04/2004 - 02/2004
1Interleukin-27 (Interleukin 27)IBA
01/2021
1Sirtuin 1IBA
01/2021
1Epidermal Growth Factor (EGF)IBA
10/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Immune Checkpoint ProteinsIBA
01/2020
1Proto-Oncogene Proteins B-rafIBA
01/2020
1Serum AlbuminIBA
01/2020
1HomoharringtonineIBA
01/2020
1Therapeutic UsesIBA
12/2019
1IgE Receptors (Fc epsilon RI)IBA
10/2019
1Tyrosine Kinase InhibitorsIBA
09/2019
1AntibodiesIBA
09/2019
1Phosphatidylinositols (Phosphatidylinositol)IBA
09/2019
1Beclin-1IBA
01/2018
1Interleukin-5 (Interleukin 5)IBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2018
1Histamine (Histamine Dihydrochloride)FDA Link
01/2018
1Chemokine CXCL2IBA
01/2018

Therapy/Procedure

10Therapeutics
05/2022 - 06/2007